Standout Papers

Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis 2020 2026 2022 2024192
  1. Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis (2020)
    James D. Chalmers, Charles Haworth et al. New England Journal of Medicine

Immediate Impact

3 from Science/Nature 63 standout
Sub-graph 1 of 19

Citing Papers

Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Shining New Light on Biological Systems: Luminescent Transition Metal Complexes for Bioimaging and Biosensing Applications
2024 Standout
2 intermediate papers

Works of Anne E. O’Donnell being referenced

Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
2020 Standout
A Phase I Study of a New Nucleoside Analogue, OSI-7836, Using Two Administration Schedules in Patients with Advanced Solid Malignancies
2006

Author Peers

Author Last Decade Papers Cites
Anne E. O’Donnell 1449 579 190 207 46 1.9k
Pieter Goeminne 2345 589 170 298 59 2.7k
Dennis C. Stokes 1349 527 176 102 75 2.5k
David de la Rosa 2223 484 109 155 87 2.5k
Thomas C. Fardon 1828 442 76 183 26 2.0k
Gregory Tino 1453 379 90 180 38 1.9k
Rosa Girón 1809 475 138 144 133 2.1k
Conroy Wong 1124 423 116 75 51 2.1k
Antoni Torres 862 897 253 69 30 2.0k
Preston W. Campbell 2281 443 121 96 36 2.9k
Noel Karalus 795 623 155 55 28 1.4k

All Works

Loading papers...

Rankless by CCL
2026